P1.01-33 Randomized Phase 2 Study Comparing CBDCA+PTX+BEV and CDDP+PEM+BEV in Treatment-Naïve Advanced Non-Sq NSCLC (CLEAR study)doi:10.1016/j.jtho.2018.08.589Harada, T.Udagawa, H.Sugiyama, E.Atagi, S.Koyama, R.Watanabe, S.